NIDDM PRIMARY PREVENTION TRIAL (DPT-2)

Project: Research project

Description

The objectives of this research proposal is to participate as a clinical
center in a multicenter trial to determine whether the development of non-
insulin dependent diabetes (NIDDM) can be prevented. We propose to
identify 200 subjects at high risk for developing NIDDM over a 12-month
period. Group I subjects with impaired glucose tolerance (IGT) will be
identified from the African-American minority group by oral glucose
tolerance testing (OGTT) and Group Il subjects with IGT will be identified
from a large data base of women who have had post-gestational diabetes.
In the course of screening these populations, it is anticipated that a
proportion of subjects with undiagnosed diabetes will be identified by
OGTT. Those without fasting hyperglycemia (
StatusActive
Effective start/end date8/20/941/31/21

Funding

  • National Institutes of Health: $459,000.00
  • National Institutes of Health: $343,806.00
  • National Institutes of Health: $684,655.00
  • National Institutes of Health: $384,993.00
  • National Institutes of Health: $539,362.00
  • National Institutes of Health: $381,292.00
  • National Institutes of Health: $486,801.00
  • National Institutes of Health: $406,034.00
  • National Institutes of Health: $340,244.00
  • National Institutes of Health: $582,564.00
  • National Institutes of Health: $750,062.00
  • National Institutes of Health: $441,632.00
  • National Institutes of Health: $403,517.00
  • National Institutes of Health: $407,812.00
  • National Institutes of Health
  • National Institutes of Health: $563,073.00
  • National Institutes of Health: $334,465.00
  • National Institutes of Health: $414,556.00
  • National Institutes of Health
  • National Institutes of Health: $23,952.00
  • National Institutes of Health: $305,924.00
  • National Institutes of Health: $628,883.00
  • National Institutes of Health
  • National Institutes of Health: $207,841.00
  • National Institutes of Health
  • National Institutes of Health: $459,000.00
  • National Institutes of Health: $39,910.00
  • National Institutes of Health: $269,622.00
  • National Institutes of Health
  • National Institutes of Health: $345,105.00

Fingerprint

Glucose Intolerance
Type 2 Diabetes Mellitus
Primary Prevention
Metformin
Outcome Assessment (Health Care)
Glucose Tolerance Test
Minority Groups
Gestational Diabetes
Life Style
Cardiovascular Diseases
Hyperglycemia
African Americans
Population
Multicenter Studies
Fasting
Research Design
Databases
Research
Atherosclerosis
Insulin

ASJC

  • Medicine(all)